These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28535470)

  • 1. Pharmacophore guided discovery of small-molecule interleukin 15 inhibitors.
    Żyżyńska-Granica B; Trzaskowski B; Niewieczerzał S; Filipek S; Zegrocka-Stendel O; Dutkiewicz M; Krzeczyński P; Kowalewska M; Koziak K
    Eur J Med Chem; 2017 Aug; 136():543-547. PubMed ID: 28535470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New, Low-Molecular Weight Chemical Compounds Inhibiting Biological Activity of Interleukin 15.
    Krzeczyński P; Dutkiewicz M; Zegrocka-Stendel O; Trzaskowski B; Koziak K
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization.
    Quéméner A; Maillasson M; Arzel L; Sicard B; Vomiandry R; Mortier E; Dubreuil D; Jacques Y; Lebreton J; Mathé-Allainmat M
    J Med Chem; 2017 Jul; 60(14):6249-6272. PubMed ID: 28657314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor.
    Żyżyńska-Granica B; Trzaskowski B; Dutkiewicz M; Zegrocka-Stendel O; Machcińska M; Bocian K; Kowalewska M; Koziak K
    Sci Rep; 2020 Feb; 10(1):2886. PubMed ID: 32076052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
    Hayakawa N; Noguchi M; Takeshita S; Eviryanti A; Seki Y; Nishio H; Yokoyama R; Noguchi M; Shuto M; Shima Y; Kuribayashi K; Kageyama S; Eda H; Suzuki M; Hatta T; Iemura S; Natsume T; Tanabe I; Nakagawa R; Shiozaki M; Sakurai K; Shoji M; Andou A; Yamamoto T
    Bioorg Med Chem; 2014 Jun; 22(11):3021-9. PubMed ID: 24767819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Li Y
    Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
    Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of small molecule inhibitors of IL-15Rα using molecular docking and surface plasmon resonance technology].
    He Y; Wang HX; Liu M; Yang J; Sun ZL
    Sheng Li Xue Bao; 2023 Oct; 75(5):623-628. PubMed ID: 37909133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.
    Santos Savio A; Machado Diaz AC; Chico Capote A; Miranda Navarro J; Rodríguez Alvarez Y; Bringas Pérez R; Estévez del Toro M; Guillen Nieto GE
    BMC Musculoskelet Disord; 2015 Mar; 16():51. PubMed ID: 25879761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation.
    Meghnem D; Maillasson M; Barbieux I; Morisseau S; Keita D; Jacques Y; Quéméner A; Mortier E
    Front Immunol; 2022; 13():886213. PubMed ID: 35592318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
    Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
    J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Ding N; Zhang W; Li Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of highly potent TNFα inhibitors using virtual screen.
    Shen Q; Chen J; Wang Q; Deng X; Liu Y; Lai L
    Eur J Med Chem; 2014 Oct; 85():119-26. PubMed ID: 25078315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations.
    Panicker PS; Melge AR; Biswas L; Keechilat P; Mohan CG
    Chem Biol Drug Des; 2017 Oct; 90(4):629-636. PubMed ID: 28303669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15Ralpha chain.
    Ratthé C; Girard D
    J Leukoc Biol; 2004 Jul; 76(1):162-8. PubMed ID: 15123770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).
    Halland N; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schreuder HA; Kallus C
    J Med Chem; 2016 Oct; 59(20):9567-9573. PubMed ID: 27749053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
    Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
    J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists.
    Liu S; Dakin LA; Xing L; Withka JM; Sahasrabudhe PV; Li W; Banker ME; Balbo P; Shanker S; Chrunyk BA; Guo Z; Chen JM; Young JA; Bai G; Starr JT; Wright SW; Bussenius J; Tan S; Gopalsamy A; Lefker BA; Vincent F; Jones LH; Xu H; Hoth LR; Geoghegan KF; Qiu X; Bunnage ME; Thorarensen A
    Sci Rep; 2016 Aug; 6():30859. PubMed ID: 27527709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-of-the-art of small molecule inhibitors of the TAM family: the point of view of the chemist.
    Baladi T; Abet V; Piguel S
    Eur J Med Chem; 2015 Nov; 105():220-37. PubMed ID: 26498569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.